Drug Target Review2025-02-04T08:00:04
A new AI-powered approach is tackling the challenge of 'undruggable' diseases by designing peptides that can bind to and destroy previously untreatable proteins.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2026-08-17T14:16:00
Contributor Dr Rab Prinjha, Drug Target Review
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2026-05-26T09:05:00
Contributor Thomas Clozel M.D., Drug Target Review
2023-03-30T09:15:30
Sponsored by Halo Labs
2024-01-10T08:56:17
Sponsored by Leica Microsystems
Site powered by Webvision Cloud